Research Articles | Page 20 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Randomized Open-Label Phase II Study of Decitabine in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes. Jun 2013 J Clin Oncol myelodysplastic syndromes (MDS)
Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations. Jun 2013 Blood Res myelodysplastic syndromes (MDS)
Dendritic cells in myelodysplastic syndromes: from pathogenesis to immunotherapy. Jun 2013 Immunotherapy myelodysplastic syndromes (MDS)
Higher-risk myelodysplastic syndromes with del(5q): is sequential azacitidine-lenalidomide combination the way to go? Jun 2013 Expert Rev Hematol myelodysplastic syndromes (MDS)
Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine. Jun 2013 Ann Hematol myelodysplastic syndromes (MDS)
Aplastic anemia: what have we learned from animal models and from the clinic. Jun 2013 Semin Hematol aplastic anemia
Increased parameters of oxidative stress and its relation to transfusion iron overload in patients with myelodysplastic syndromes. Jun 2013 J Clin Pathol myelodysplastic syndromes (MDS)
Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes. Jun 2013 Leukemia myelodysplastic syndromes (MDS)
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes. Jun 2013 Bone Marrow Transplant myelodysplastic syndromes (MDS)
ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ADULTS WITH MYELODYSPLASTIC SYNDROMES (MDS): RELEVANCE OF PRE-TRANSPLANT DISEASE STATUS. Jun 2013 Leuk Lymphoma myelodysplastic syndromes (MDS)
Share with addtoany.com.